LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi, a leading provider of injectable medications, announced today it has launched Rocuronium Bromide Injection with advanced RFID-enabled labels in the ...

Mumbai: The global pharmaceutical company Lupin Limited (Lupin) has announced the release of Rocuronium Bromide injection in two variations: 50 mg/5 mL (10 mg/mL) and 100 mg/10 mL (10 mg/mL) ...

BETHLEHEM, Pa., May 4, 2026 /PRNewswire/ -- B. Braun Medical Inc. (B. Braun), a recognized leader in smart infusion therapy and pharmaceutical manufacturing, announced the launch of Rocuronium Bromide ...

Fresenius Kabi, an operating company of Fresenius, and a leading provider of essential medicines and medical technologies, announced it has launched rocuronium bromide injection room temperature ...

Fresenius Kabi, a provider of injectable medications, has announced the U.S. launch of its Rocuronium Bromide Injection, a product offered with RFID-enabled labels. Rocuronium Bromide Injection is ...

- Launch accelerated in response to market impacts anticipated from the natural disaster at Pfizer's Rocky Mount, NC drug manufacturing facility - KinetiX Rocuronium Bromide Injection will be offered ...

The injections are the generic version of Zemuron Bromide Injection, 50 mg/5 mL and 100 mg/10 mL of Organon USA Inc, and will be used as an adjunct to general anaesthesia. The injections are the ...

These are the generic equivalent of Zemuron bromide Injection, 50 mg/5 mL and 100 mg/10 mL of Organon USA Inc, Lupin said. (Representative Image) Pharmaceuticals firm Lupin Ltd on Monday said its ...

https://www.thehindubusinessline.com/markets/lupin-ltd-introduces-rocuronium-bromide-injection-shares-up/article67511740.ece Copy Lupin Limited’s shares were up by ...